Aplastic anemia is more common in the Orient than in western countries, with an incidence in Thailand that is 2- to 3-fold higher than in Europe. Aplastic anemia after hepatitis is a well characterized clinical entity, and clinical hepatitis is also prevalent in the Far East. We performed a prospect
Marrow transplantation in hepatitis-associated aplastic anemia
β Scribed by Robert P. Witherspoon; Rainer Storb; Howard Shulman; C. Dean Buckner; H. Joachim Deeg; Reginald A. Clift; Jean E. Sanders; Kristine Doney; George McDonald; Keith M. Sullivan; Fred R. Appelbaum; E. Donnall Thomas
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- English
- Weight
- 700 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A 14-year-old boy presented with aplastic anemia 3 months after contracting rubella. Stem cell transplantations from his identical twin were carried out. Successful engraftment occurred only when conditioning therapy was given prior to the infusion of the syngeneic stem cells, supporting an immune m
Hepatitis-associated aplastic anemia (HAAA) is an uncommon disorder that usually is not due to hepatitis A or B virus infection. Hepatitis C virus (HCV) seropositivity is infrequently observed in aplastic anemia (AA) patients who have not been extensively transfused. However, HCV seropositivity may
Fulminant hepatic failure of unknown origin is the most common cause of fulminant hepatitis with high incidence of aplastic anaemia. Furthermore, the association of liver failure and aplastic anaemia has an increased mortality rate. In this report we describe a 16-month-old boy who presented with ap